NCT02037594

Brief Summary

This study identifies social and behavioral factors likely to influence PrEP acceptability and adherence among men who have sex with men (MSM), and collaborates with a community health center to evaluate a two-stage intervention to improve PrEP decision-making, as well as persistence and adherence for those who chose to take PrEP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
438

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 16, 2014

Completed
14 days until next milestone

Study Start

First participant enrolled

January 30, 2014

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

October 11, 2018

Status Verified

October 1, 2018

Enrollment Period

3.3 years

First QC Date

January 14, 2014

Last Update Submit

October 9, 2018

Conditions

Keywords

HIVPre-exposure prophylaxisPrEPMSMDemonstration Project

Outcome Measures

Primary Outcomes (4)

  • PrEP Uptake

    Whether or not the patient decides to take PrEP

    BL through 3-months

  • PrEP Persistence

    Whether or not patients who decide to take PrEP persist with the medication for the duration of the study.

    BL through 12-months

  • PrEP Adherence

    Biological measure of medication adherence using dried blood spots, and self-report measure of adherence using VAS.

    BL through 12 months

  • Sexual Risk Behavior

    Measured through STI testing and self-report.

    BL through 12-months

Study Arms (4)

Counseling + SOC Adherence

EXPERIMENTAL

Sexual Health Counseling followed by Standard of Care Adherence Support

Behavioral: Sexual Health CounselingBehavioral: Standard of Care Adherence Support (Active Control)

Counseling + Enhanced Adherence

EXPERIMENTAL

Sexual Health Counseling followed by Enhanced Adherence Intervention

Behavioral: Sexual Health CounselingBehavioral: Enhanced Adherence Intervention

Information + SOC Adherence

EXPERIMENTAL

PrEP Information followed by Standard of Care Adherence Support

Behavioral: PrEP Information (Active Control)Behavioral: Standard of Care Adherence Support (Active Control)

Information + Enhanced Adherence

EXPERIMENTAL

PrEP Information followed by Enhanced Adherence Intervention

Behavioral: Enhanced Adherence InterventionBehavioral: PrEP Information (Active Control)

Interventions

This brief intervention presents PrEP within the context of a patient's comprehensive sexual health plan and is designed to enhance decision-making around PrEP use and decrease sexual risk taking.

Counseling + Enhanced AdherenceCounseling + SOC Adherence

This brief intervention is provides standard of care PrEP adherence information plus specific counseling, troubleshooting, and support.

Counseling + Enhanced AdherenceInformation + Enhanced Adherence

Standard of Care Information about PrEP

Information + Enhanced AdherenceInformation + SOC Adherence

Standard of care information and instruction about PrEP adherence.

Counseling + SOC AdherenceInformation + SOC Adherence

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Registered patient receiving medical or health services at Callen-Lorde Community Health Center
  • Male sex (at birth) and reported sex with men or transwomen
  • At least 18 years of age
  • HIV-negative
  • At risk for HIV acquisition

You may not qualify if:

  • Past history of PrEP use or currently taking PrEP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Callen-Lorde Community Health Center

New York, New York, 10011, United States

Location

Related Links

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Sarit A Golub, PhD, MPH

    Hunter College, CUNY

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 14, 2014

First Posted

January 16, 2014

Study Start

January 30, 2014

Primary Completion

June 1, 2017

Study Completion

June 1, 2018

Last Updated

October 11, 2018

Record last verified: 2018-10

Locations